Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.8%

3 terminated/withdrawn out of 34 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A
20(71.4%)
Phase 2
5(17.9%)
Phase 1
1(3.6%)
Phase 3
1(3.6%)
Phase 4
1(3.6%)
28Total
N/A(20)
Phase 2(5)
Phase 1(1)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials
NCT04322136Not ApplicableCompleted

AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

Role: collaborator

NCT05204550Phase 2Completed

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Role: collaborator

NCT03148600Not ApplicableCompleted

Rehabilitation After Ileo-anal Pouch Surgery

Role: lead

NCT07001553Completed

Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

Role: collaborator

NCT07225465Phase 2Not Yet Recruiting

Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin

Role: lead

NCT07017686Not ApplicableRecruiting

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Role: collaborator

NCT02617186Not ApplicableActive Not Recruiting

Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT

Role: collaborator

NCT06839248Not ApplicableRecruiting

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Role: lead

NCT06716437Not ApplicableRecruiting

Prehabilitation for Patients Undergoing Lung Cancer Surgery

Role: collaborator

NCT04970446Phase 1Recruiting

Microbial Restoration in Inflammatory Bowel Diseases

Role: lead

NCT06368466Not ApplicableCompleted

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Role: collaborator

NCT05120856Not ApplicableCompleted

AAT-App Outpatient Trial

Role: collaborator

NCT05117723Recruiting

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer

Role: lead

NCT05184101Phase 2Withdrawn

Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)

Role: collaborator

NCT03078634Not ApplicableCompleted

The Multi-disciplinary Treatment of Functional Gut Disorders Study

Role: lead

NCT06082128Not ApplicableUnknown

FOCUSau: A Dyadic Digital Health Intervention to Improve the Wellbeing of People With Advanced Cancer and Their Carers

Role: collaborator

NCT03177044Not ApplicableCompleted

Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease

Role: lead

NCT03897062Phase 2Terminated

Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence

Role: collaborator

NCT05442918Completed

Expected Normal Ketone Values After Very Low and Bariatric Surgery

Role: lead

NCT04061551Not ApplicableUnknown

Eliminate Hepatitis C/EC Partnership Evaluation Protocol

Role: collaborator